Prostate Cancer Forecast in 18 Major Markets 2016-2026: Split by Gender Type & 5 Year Age Cohort - Research and Markets

News provided by

Research and Markets

03 Feb, 2017, 13:10 GMT

DUBLIN, Feb 3, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Prostate Cancer Forecast in 18 Major Markets 2016-2026" report to their offering.

Prostate cancer is one of the most common cancers in men. The prostate, found only in men, is the size and shape of a walnut and grows bigger with age. It sits underneath the bladder and in front of the rectum. It surrounds part of the urethra which is a tube that carries urine from the bladder. A key function of the prostate is the production of semen. Prostate Cancer is predominantly a disease of older men but around 20-30% of cases occur in men under the age of 65 years of age.

This report provides the current incident population for Prostate Cancer across 18 Major Markets, split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Prostate Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Symptoms of prostate cancer can be similar to those of patients with benign prostatic hyperplasia (BPH), but can include lower urinary tract symptoms such as:

  • Needing to urinate more frequently, often during the night (nocturia)
  • Needing to rush to the toilet (urgency)
  • Difficulty in starting to urinate (hesitancy)
  • Straining or taking a long time while urinating
  • Weak flow
  • Feeling that the bladder has not emptied fully

Key Topics Covered:

  1. List of Tables and Figures
  2. Introduction
  3. Cause of the Disease
  4. Risk Factors & Prevention
  5. Diagnosis of the Disease
  6. Variation by Geography/Ethnicity
  7. Disease Prognosis & Clinical Course
  8. Key Co-morbid Conditions/Features Associated with the Disease
  9. Methodology for Quantification of Patient Numbers
  10. Top-Line Incidence for Prostate Cancer
  11. Features of Prostate Cancer Patients
  12. Prostate Cancer by Stage
  13. Treated Prostate Cancer Patients by Hormonal Status
  14. Abbreviations used in the Report
  15. Other Black Swan Analysis Publications
  16. Online Pricing Data and Platforms
  17. References
  18. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/3xbtw6/prostate_cancer

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716